UNLOCKING THE POTENTIAL OF JARDIANCE: A COMPREHENSIVE GUIDE

Jardiance is a diabetes medication that can help people with type 2 diabetes control their blood sugar. But research has shown that the medication may have other effects, too, including stimulating weight loss. And while Jardiance isn’t a weight loss medication per se, the use of diabetes medication to aid in weight management isn’t new. Drugs such as Ozempic are FDA-approved for treating type 2 diabetes but have also been shown to produce significant weight loss, making them a popular option for the treatment of diabetes in people who also have obesity.

UNDERSTANDING JARDIANCE

Jardiance, manufactured by Boehringer Ingelheim Pharmaceuticals, contains empagliflozin, an active ingredient categorized as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It’s FDA-approved for various purposes, including lowering the risk of heart failure and cardiovascular death in adults with heart disease and type 2 diabetes mellitus, and improving blood sugar control in adults with type 2 diabetes mellitus, alongside diet and exercise.

The mechanism of action involves preventing the kidneys from reabsorbing glucose into the bloodstream, thereby assisting in the removal of excess sugar from the body and reducing blood sugar levels.

CAN JARDIANCE HELP WITH WEIGHT LOSS?

While not specifically approved for weight loss, studies suggest that Jardiance may contribute to weight reduction in some individuals. Clinical trials have demonstrated that adults using Jardiance experienced an average weight loss of 2.8% to 3.2% of their baseline weight. Additionally, combining Jardiance with other diabetes medications and lifestyle modifications like diet and exercise can enhance weight loss effects.

Moreover, research indicates that Jardiance may target visceral adiposity, reducing belly fat—a significant risk factor for diabetes and cardiovascular diseases.

UNDERSTANDING JARDIANCE SIDE EFFECTS AND WARNINGS

Like any medication, Jardiance comes with potential side effects and warnings. Common side effects include urinary tract infections, genital fungal or yeast infections, increased urination, high cholesterol, and joint pain. While most side effects are mild to moderate, serious complications such as low blood sugar, diabetic ketoacidosis, dehydration, Fournier’s gangrene, hypersensitivity reactions, and adverse effects on pregnancy, breastfeeding, and severe kidney disease may occur. It’s essential to discuss any concerns with a healthcare provider.

OPTIMIZING JARDIANCE USAGE FOR WEIGHT LOSS

To maximize the benefits of Jardiance while minimizing risks, it’s crucial to take the medication as prescribed by a healthcare provider. The recommended dosage should be taken in the morning, preferably around the same time daily, with or without meals. Consistency in dosage timing is key to maintaining therapeutic effects.

If considering discontinuation of Jardiance due to side effects or other reasons, consulting a healthcare provider is essential to assess potential alternatives and ensure a safe transition.

CONCLUSION

Jardiance offers multifaceted benefits beyond blood sugar control, including potential weight loss effects. However, it’s essential to weigh the benefits against potential risks and adhere to prescribed usage guidelines. With proper monitoring and lifestyle modifications, Jardiance can be a valuable tool in managing type 2 diabetes and promoting overall health and well-being.

CALL TO ACTION

At Aktwisted Wellness, we are committed to helping you achieve optimal health through personalized care and support. If you are considering Jardiance for diabetes management or weight loss, contact us today to schedule a consultation. Our team of experts will guide you through your treatment options and help you make informed decisions for your health and wellness.

Disclaimer:

This blog post serves as an informational resource and should not replace professional medical advice. Individuals should consult their healthcare providers for personalized guidance regarding medication usage, side effects, and treatment options. The information provided herein is based on current research and medical knowledge but is not a substitute for individualized healthcare consultation.

SOURCES

1. Boehringer Ingelheim Pharmaceuticals. (2020). Jardiance (empagliflozin) prescribing information. Retrieved from boehringer-ingelheim.com
2. Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., … & EMPA-REG OUTCOME Investigators. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), 2117-2128.
3. Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., … & CANVAS Program Collaborative Group. (2017). Canagliflozin and cardiovascular and renal events in type 2 diabetes. New England Journal of Medicine, 377(7), 644-657.
4. Fitchett, D., Zinman, B., Wanner, C., Lachin, J. M., Hantel, S., Salsali, A., … & Bluhmki, E. (2016). Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial. European Heart Journal, 37(19), 1526-1534.
5. Ferrannini, E., Mark, M., & Mayoux, E. (2015). CV protection in the EMPA-REG OUTCOME trial: a “thrifty substrate” hypothesis. Diabetes Care, 39(8), 1108-1114.